SciDEX — Wiki (38 pages)

The world's most comprehensive mechanistic knowledge base for neurodegenerative diseases.

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Scientific World Model

What is the Scientific World Model?

💊 Sulforaphane and Nrf2 Activation for NeuroprotectionKG

💊 Neuroprotection Strategies in NeurodegenerationKG

💊 Creatine for NeuroprotectionKG

🏢 Alzheimer's Disease Synaptic Repair and Neuroprotection CompaniesKG

💊 Mitochondrial Support Strategies for CBS/PSPKG

⚙️ Lactoferrin Neuroprotection in Neurodegenerative DiseasesKG

⚙️ Irisin (FNDC5) - Exercise-Induced Myokine for NeurodegenerationKG

⚙️ Tea Polyphenols for NeuroprotectionKG

💡 NfL-Guided Neuroprotection ThresholdKG

💡 ESCRT-III Neuroprotection Therapy for NeurodegenerationKG

MDS 2026: Neuroprotection and Neurorestorative Strategies for Parkinson's DiseaseKG

⚙️ Gasotransmitters in Neuroprotection - AD/PDKG

💊 Exercise and Physical Activity for NeuroprotectionKG

🔬 Neuroprotective MicrogliaKG

⚙️ Hypoxia Neuroprotection in Sporadic Parkinson's DiseaseKG

⚙️ FGF13-MTCH2 Neuroprotection in Parkinson's DiseaseKG

🔬 Serpin Neuroprotection in NeurodegenerationKG

⚙️ Exercise and NeuroprotectionKG

⚙️ Ginsenosides Neuroprotection in Parkinson's DiseaseKG

💡 CB1 Receptor Endocannabinoid Modulation for NeuroprotectionKG

💡 EP2 Receptor Antagonism for NeuroprotectionKG

⚙️ DJ-1/PARK7 Neuroprotection Pathway in Parkinson's DiseaseKG

💊 Lithium in NeurodegenerationKG

⚙️ PARK7/DJ-1 Neuroprotection Pathway — Parkinson's Disease Causal ChainKG

💡 CD38 Inhibition + NAD+ Precursor Synergy for NeuroprotectionKG

💊 NfL-Guided Neuroprotection ThresholdKG

💡 Galectin-3 Modulation for NeuroprotectionKG

⚙️ Cryptoxanthin NeuroprotectionKG

💊 NRF2 Activators in Neurodegenerative DiseaseKG

Hormone Neuroprotection in CBS/PSPKG

🧫 GLP-1 Agonist Neuroprotection Mechanism in PDKG

Silymarin for Neuroprotection and Symptom Management in Parkinson's Disease (NCT07001150)KG

🏢 Parkinson's Disease Mitochondrial Neuroprotection Companies

💡 NfL-Guided Neuroprotective Therapy for Rapid ProgressorsKG

🧫 GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neuroprotection in PDKG

💡 NfL-Guided Neuroprotection TherapyKG

💡 SGLT2 Inhibitor Neuroprotection TherapyKG

💡 Perivascular Macrophage Neuroprotection TherapyKG